Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN11 | Q06124 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | RARB | P10826 | 3/20 | 0.45 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | KDM4A | O75164 | 1/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.42 |
| ▸ | PLK1 | P53350 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12228454 | 0.95 | PTPN11 (0.52) | PTPN11MAPTRARBPLA2G2ARAB9A | |
| SCHEMBL9608527 | 0.90 | PTPN11 (0.53) | PTPN11MAPTMEN1KMT2ANPSR1 | |
| SCHEMBL12228409 | 0.90 | PLA2G2A (0.50) | PTPN11MAPTRARBPLA2G2A | |
| SCHEMBL23285271 | 0.89 | PTPN11 (0.46) | PTPN11MAPTMEN1KMT2ANPSR1 | |
| SCHEMBL12754391 | 0.89 | MAPT (0.50) | MAPTMEN1POLBKMT2ANPSR1 | |
| SCHEMBL9609332 | 0.87 | MAPT (0.48) | MAPTMEN1KMT2ANPSR1RAB9A | |
| SCHEMBL12755012 | 0.87 | RARB (0.48) | PTPN11MAPTKMT2ARARBPLK1 | |
| SCHEMBL1630438 | 0.84 | PTPN11 (0.52) | PTPN11RARB | |
| SCHEMBL10090891 | 0.84 | PTPN11 (0.52) | PTPN11RARB | |
| SCHEMBL5550301 | 0.84 | PTPN11 (0.52) | PTPN11RARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160200933-A1 | RESIN COMPOSITION, PROTECTIVE FILM FOR POLARIZING PLATE, POLARIZING PLATE, AND DISPLAY | FUJIFILM CORPORATION (JP) | 2016-07-14 | — | — | US | disclosed |
| US-8957140-B2 | Triazine derivative, ultraviolet absorber, and resin composition | FUJIFILM CORPORATION (JP) | 2015-02-17 | — | — | US | disclosed |
| US-8748520-B2 | Polycarbonate resin composition containing triazine compound and molded article using the same | FUJIFILM CORPORATION (JP) | 2014-06-10 | — | — | US | disclosed |
| US-8623990-B2 | Polyester resin composition | FUJIFILM CORPORATION (JP) | 2014-01-07 | — | — | US | disclosed |
| US-20120301696-A1 | POLYESTER RESIN COMPOSITION | FUJIFILM CORPORATION (JP) | 2012-11-29 | — | — | US | disclosed |
| US-20120136098-A1 | NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION | FUJIFILM CORPORATION (JP) | 2012-05-31 | — | — | US | disclosed |
| US-20110077331-A1 | POLYCARBONATE RESIN COMPOSITION CONTAINING TRIAZINE COMPOUND AND MOLDED ARTICLE USING THE SAME | FUJIFILM CORPORATION (JP) | 2011-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120136098-A1 | NEW TRIAZINE DERIVATIVE, ULTRAVIOLET ABSORBER, AND RESIN COMPOSITION | C1R, RPSA, H1-2 | PTPN11 4364/4885MAPT 1774/4885MEN1 2282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.